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Summary
Biocatalysis has become a useful alternative to chemical transformations for the pro-
duction of a range of compounds with applications in the food, feed, chemical and phar-
maceutical industries. However, it is not necessarily an easy task to obtain the desired lev-
els of performance in terms of rate, yield and selectivity of the reaction. One strategy for
optimizing biocatalyst performance is to use non-conventional media, such as non-aque-
ous heterogeneous systems. In this article, we highlight some of the current trends in
biocatalysis in such systems, focusing on reverse micelles, supercritical fluids and ionic liq-
uids.
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Introduction
In biocatalysis, the term non-conventional media re-
fers to systems that use solvents other than water or the
addition of components to aqueous systems with the in-
tention of favoring specific properties of the biocatalyst
or the reaction catalyzed by it. Non-conventional media
can be used for biocatalysis with either enzymes or
whole cells.
The solvent can cause modifications in the confor-
mation of the enzyme, altering either its catalytic effi-
ciency or specificity. For example, through the rational
use of non-conventional media, it may be possible to in-
crease the enantioselectivity of the reaction catalyzed by
the biocatalyst. Non-aqueous reaction media may also
increase the stability of the enzyme (1–3). A further ad-
vantage is that the risk of microbial contamination is
lower than is the case in aqueous systems. Non-conven-
tional media are of special interest for hydrolases since
low water contents can be used in order to favor synthe-
sis reactions and, in the case of lipases, to provide better
solubility of hydrophobic substrates.
The water-restricted organic systems used in bioca-
talysis can be classified as heterogeneous and homoge-
neous. Homogeneous systems are reviewed by Torres
and Castro (4). Heterogeneous systems include liquid-
-liquid macro-heterogeneous systems, in which water
represents 1 to 5 % of the reaction medium, liquid-solid
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macro-heterogeneous systems and micro-heterogeneous
systems. This mini-review highlights some of the recent
developments in the use of heterogeneous non-conven-
tional media for biocatalysis, such as reverse micelles,
supercritical fluids and ionic liquids.
General Considerations about Biocatalysis in
Non-Conventional Heterogeneous Media
In macro-heterogeneous systems there is a visible
separation of phases, such as systems that use immobi-
lized enzymes or powdered enzymes. In micro-hetero-
geneous systems the separation of phases can only be
observed microscopically, such as is the case with re-
verse micelles. In reverse micelles, the amount of water
in the system is generally expressed in terms of the pa-
rameter W0 (H2O/surfactant), while in other systems
it is expressed in terms of the water activity (aw) (5–8).
In the case of reactions catalyzed by hydrolases, the
amount of water can be manipulated to favor either
synthesis or hydrolysis reactions. In the reversed micel-
lar system it also affects the size of the micelles and the
conformation of the enzyme within the micelles.
Unfortunately, despite the advantages that bioca-
talysis in organic solvent-based systems can bring, the
catalytic activities of enzymes in these systems are typi-
cally much lower than activities in aqueous solutions
(9). Further, protein stability is lower in water-miscible
solvents (–2.5<log P<0), such as acetone and ethers, than
in hydrophobic solvents (2<log P<4), such as alkanes or
haloalkanes. Hydrophobic organic solvents do not strip
off the crucial bound water from the enzyme surface
(10–12), while hydrophilic organic solvents strip this
water from the enzymes, leading to the unfolding of the
molecule (13). As a result, acceptable stability of bacte-
rial and fungal enzymes in hydrophilic organic solvents
is rare. Two enzymes that are reasonably stable in hy-
drophilic organic solvents are a lipase of Pseudomonas
mendocina PK12CS (14), which maintained an 83 % re-
sidual activity after 2.5 h incubation in 100 % ethanol,
and a lipase of Bacillus megaterium CCOC-P2637, which
was not only stable but also showed activation at etha-
nol and acetone volume fraction as high as 80 % and
maintained its activity in pure isopropanol (15). How-
ever, the general lack of stability in hydrophilic solvents
represents a problem for the use of hydrolases, such as
in reactions involving the esterification of sugars during
the production of biosurfactants, given that in these re-
actions the medium contains polar solvents such as
2-metil-2-butanol (16).
Successful biocatalysis in non-conventional media
has been reported, the main applications being in ester
and peptide synthesis, the resolution of chiral building
blocks and the production of cocoa butter substitutes
(17). Four of the fifteen industrial processes using hy-
drolases cited by Krishna (18) are carried out in the pre-
sence of organic solvents: the synthesis of chiral amines
and alcohols in MTBE-ethylmethoxy acetate, the synthe-
sis of an anti-cholesterol drug in toluene, the generation
of an intermediate in the synthesis of Diltiazem in a wa-
ter-toluene mixture and the synthesis of isopropyl pal-
mitate and myristate in 2-propanol.
Reverse Micelles
The low water content necessary to favor synthesis
reactions in organic media by hydrolases can be achieved
by micro-encapsulation of the biocatalyst within reverse
micelles. Reverse micelles are relatively ordered struc-
tures that consist of a water pool surrounded by a sur-
factant layer, with the hydrophobic moieties of the sur-
factant molecules interacting with the bulk hydrophobic
solvent (Fig. 1). Since they are dynamic structures, the
micelles can exchange their constituents (biocatalyst,
water, substrates and products) between each other and
also with the bulk organic solvent. The reversed micel-
lar system is particularly attractive for biocatalysis be-
cause it mimics the »natural« environment that many
enzymes experience within cells. Many surfactants and
solvents can be used, the AOT (sodium bis-2-ethylhexyl
sulfosuccinate)/isooctane system being one of the most
suitable systems (19–22), since the reverse micelles formed
by this surfactant are very stable over a wide range of
concentrations in the absence of co-surfactants.
The reversed micellar system is especially interest-
ing for lipases, which are activated in the presence of an
interface, since this system provides a high interfacial
area, with the enzyme anchoring on the aqueous side of
the AOT interface. In addition, lipase-catalyzed reac-
















Fig. 1. (a) Schematic representation of a reverse micelle, and (b) the chemical structure of AOT (sodium bis-2-ethylhexyl sulfo-
succinate)
tions often involve hydrophobic substrates, which are
readily soluble in the bulk organic phase. Further, some
enzymes are highly stable in reverse micelles, such as
-chymotrypsin and the lipase of Chromobacterium vis-
cosum (23).
Due to the complexity of the reversed micelle sys-
tem, with the addition of different enzymes, buffers,
salts, substrates and products influencing the size and
shape of the micelles formed, it is difficult to make pre-
dictions as to how the system will perform in a specific
case. The selection of the reversed micelle system is typ-
ically based on the successes reported in the literature
for similar enzymes and reactions (23,24). Table 1 re-
ports some such reactions, with potential applications in
the food, pharmaceutical and chemical industries and
also in the environmental area (15,25–30).
The results reported for reversed micellar systems
for the synthesis of esters with applications in the food
sector, such as ester-based aromas, are better, in terms
of overall conversion and reaction rate, than those re-
ported for other water-restricted media. For instance, for
ethyl-laurate synthesis by Thermomyces lanuginosa lipase,
a yield of 90 % was obtained after 60 min in an AOT-
-isooctane reversed micellar system (25), whereas 168 h
was required for a 95 % yield of ethyl-caproate when
lyophilized powder of the esterase of Bacillus lichenifor-
mis was added directly to n-heptane (31) and 72 h was
required for a 95 % yield of isoamyl acetate using an im-
mobilized lipase of Rhizopus miehei in isooctane (32).
Before reversed micellar systems can be effectively
applied at industrial scale, there are some issues to be
solved. It is difficult to recover the product from reverse
micelles at large scale due to the presence of the surfac-
tant and other components of the system, such as pro-
tein and water. A possible solution is continuous opera-
tion in membrane reactors in which an ultrafiltration
membrane retains the micelles and therefore also the en-
zyme, while the small molecules of substrate and prod-
ucts pass freely. Such membrane bioreactors have been
used for ester synthesis and for peptide synthesis (33,
34). The main problem of continuous membrane biore-
actors is that the enzyme needs to be stable for long pe-
riods, which is not always the case. Recently, ester syn-
thesis in such reactor was optimized at laboratory scale,
using cutinase (a small hydrolase that acts either as an
esterase or as a lipase) as the biocatalyst. A stable 60 %
conversion to the ester was achieved over five weeks of
continuous operation, during which the enzyme lost
only 20 % of its initial activity (23). Another problem of
continuous membrane bioreactors was noted: the surfac-
tant passes the membrane in the form of small aggre-
gates or as monomers, contaminating the product stream.
This makes the separation and purification of the prod-
uct more difficult, especially when it is to be used in
food or pharmaceuticals or other products that require
either non-toxic or highly pure products (23).
Supercritical Fluids (scF)
Enzymes can express activity in supercritical and
near-supercritical fluids, such as carbon dioxide, freons
(CHF3), hydrocarbons (ethane, ethene, propane) or inor-
ganic compounds (SF6, N2O). The most commonly used
system is supercritical carbon dioxide (scCO2), which is
probably explained by the fact that its critical point of
73.8 bar and 31.1 °C makes equipment design and reac-
tion set-up relatively simple (17). Supercritical fluids,
which represent a state between the gaseous and liquid
phases of the compound, exhibit properties similar to
those of hydrophobic solvents such as hexane, so it is
likely that the activities and stabilities of enzymes in
these systems will be similar to those presented in hydro-
phobic solvents. Although the use of supercritical fluids
is not restricted to hydrolases, the use of this class of en-
zymes, especially lipases, dominates (Table 2) (35–57).
Small changes in the temperature or pressure of a
supercritical fluid may result in great changes in its vis-
cosity and of the diffusivity and solubility of com-
pounds dissolved within it. This may allow control of
the rate and enantioselectivity of enzyme-catalyzed reac-
tions. The main advantages of the system are the high
diffusion rates (one or two orders of magnitude higher
than in common solvents), which facilitate transport
phenomena and can increase the bioconversion rate. In
some cases a high diffusion rate can also facilitate prod-
uct separation. Further, supercritical fluids such as car-
bon dioxide are non-toxic and can be removed easily af-
ter the reaction. The main drawback of supercritical
reaction media is that the process requires reactors and
auxiliary equipment that can withstand high pressures,
which increases process costs. In addition, the use of
supercritical carbon dioxide can have adverse effects on
enzymes, for example, by decreasing the pH of the
microenvironment of the enzyme, by the formation of
carbamates due to covalent modification of free amino
groups at the surface of the protein and by deactivation
during pressurization/depressurization cycles (17,41).
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Table 1. Recent examples of reactions catalyzed by enzymes in reversed micellar systems
Source (Enzyme) Surfactant Organic solvent Reaction Reference
Thermomyces lanuginosa (lipase) AOT Isooctane Synthesis of ethyl-laurate 25
-chymotrypsin AOT n-heptane Hydrolysis of 2-naphthyl acetate 26
Bacillus megaterium (lipase) AOT n-heptane Hydrolysis of pNPP 15
Rhizopus delemar (lipase) AOT Isooctane Hydrolysis of triolein 27
Mucor javanicus (lipase) AOT Isooctane Acylation of doxorubicin 28
Horse heart (Microperoxidase-11) AOT Isooctane Oxidative decolorization of azo and anthraquinone dyes 29
Candida lypolytica (lipase) AOT Isooctane Esterification of octanoic acid with 1-octanol 30
Key: AOT (sodium bis-2-ethylhexyl sulfosuccinate), pNPP (p-nitrophenylpalmitate)
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Table 2. Different types of reactions catalysed by enzymes in supercritical fluids (scFs) and in ionic liquids (ILs)
Enzyme/Source System Reaction Reference Comments
Free and immobilized lipases:
Rhyzomucor meihei, P. fluorescens,
Rhizopus javanicus, R. niveus,




Ester synthesis: oleyl oleate 35 Economy of the process is given
Free and immobilized lipases:
C. antarctica, Mucor miehei
scCO2
and ILs
Synthesis of glycidyl esters:
kinetic resolution of
rac-glycidol
36 Activity up to 95-times enhanced
in ILs.






37 Reaction rates and stereoselectivity







Synthesis of biodiesel 38 Complete conversion for
scMethanol,






Hydrolysis of retinyl palmitate
and -tocopheryl acetate




scCO2 Hydrolysis of blackcurrant 40 Simultaneous extraction and
hydrolysis of the oil
Immobilized lipase:
C. antarctica




BMIM-BF6 Resolution of racemic alcohols 42 The addition of triethylamine to
ILs enhanced the rate of reaction
Immobilized C. antarctica B
lipase
ILs (several) Amine synthesis 43 Enantioselective acylation of
1-phenylethylamine in
BDMIM-TFMS
Lipase: C. rugosa BMIM-BF4,
HMIM-BF4,
BMIM-BF6
Enantioselective hydrolysis 44 ILs as co-solvents markedly
enhanced enantioselectivity




Enantioselective acylation 45 Increased reaction rate, decreased
enantioselectivity
Lipase: C. rugosa ILs (several) Esterification of
2-chloropropanoic acid
with 1-butanol
46 Highest conversion for BMIM-BF6
Immobilized esterases: Bacillus
stearothermophilus and B. subtilis
ILs (several) Transesterification of
1-phenylethanol
47 Higher stability in ILs as com-
pared to organic solvents





48 Higher enantioselectivity than in
n-hexane
Glucose oxidase: Aspergilus niger
Peroxidase: Coprinus cinereus
BMIM-BF6 Oxidation of sulfides 49 High operational stability of the
enzymes. Recycling of mixture
IL–enzymes possible
Lipase: C. rugosa BMIM-BF6,
MOEMIM-BF6
Acylation of glycosides 50 Higher reaction rates and
selectivity than in conventional
organic solvents







51 The enzyme-IL mixture could be




vinyl-acetate as acyl donor
52 The lipase was reused for 10 times
without losing enantioselectivity
and reactivity









54 All ILs improved the thermal
stability of both enzymes
Ionic Liquids (ILs)
The most exciting recent development in biocataly-
sis in non-conventional media is the use of ionic liquids
(ILs) to improve the activity, stability and selectivity of
enzymes. Ionic liquids are low melting point salts that
are liquid at room temperature. They are composed en-
tirely of ions and are considered to be highly polar sol-
vents (see Table 3) (58,61). They possess negligible va-
por pressures, which can be taken advantage of for the
separation of volatile products, such as water, driving
the reaction equilibrium towards product formation (43).
One of the main advantages of using ionic liquids as re-
action media is that, due to the wide range of possible
counter-ions, it is possible to tune their solvent proper-
ties, so that they can dissolve many different compounds
used in chemical and biochemical synthesis reactions
(58). Further, ionic liquids are claimed to contribute to
»green chemistry« since they are non-volatile at room
temperature, in contrast to organic solvents.
The application of ionic liquids as non-aqueous re-
action media in biocatalysis is still in its infancy. Until
2002 (54), only three papers described the use of ionic
liquids for hydrolase-catalyzed reactions, all of them quite
successful. Various articles have appeared since then, in-
cluding three excellent reviews about their application
in biocatalysis (59–61). Also, the review by Gordon (58)
deserves a mention because it covers chemical and bio-
chemical aspects of catalysis in ionic liquids.
Although some groups have reported contradictory
results regarding enzymatic activity in ionic liquids (60),
many biocatalyzed reactions show advantages when
carried out in ionic liquids. Table 2 presents some recent
examples of processes that were carried out in ionic liq-
uids, using enzymes and whole-cells. Claims have been
made for improved reaction rates (42,45,46,50), increased
selectivity (37,44,48,50,53), improved enzyme stability
(47,49,54) and easier recycling of the biocatalyst (49,51,
52,58).
As with supercritical fluids, many of the processes
carried out in ionic liquids have involved lipases, due to
their tolerance of organic solvents and their ability to
catalyze a broad range of reactions. With lipases, the fo-
cus is typically on the synthesis of pure enantiomers or
on the resolution of racemates (Table 2). There are also
reports of the use of ionic liquids with other enzymes,
such as mandolases (57), peroxidases and glucose oxi-
dases (49) and with whole-cells (59,61).
The first ionic liquid, reported in 1914, was EtNH3 ×
NO3 (ethylammonium nitrate) but nowadays the most
common ionic liquids for biocatalysis are imidazolium-
-based ionic liquids, such as BMIM-BF4 and BMIM-BF6
(1-butyl-3-methylimidazolium tetrafluoroborate and hexa-
fluoroborate) (Fig. 2) (18,60,62). As the application of io-
nic liquids in biocatalysis is still at an early stage, there
is not yet a well-established theoretical basis for predict-
ing the solvent properties of ionic liquids, which vary
greatly with the nature of the counter-ion. For instance,
BMIM-BF4 is water miscible, whereas BMIM-BF6 is not.
The miscibility behavior of ionic liquids and organic sol-
vents is not very well known, although it is known that
supercritical carbon dioxide does not mix with ionic liq-
uids (61). In fact, the possibility of having a solvent like
an ionic liquid, which does not mix well either with wa-
ter or with non-polar solvents, can be taken advantage
of by the use of two-phase systems. One successful ex-
ample was presented by Lozano et al. (36). They were
able to simultaneously catalyze their reaction within the
ionic liquid and remove the product by extraction into
supercritical carbon dioxide, thereby shifting the equi-
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Enzyme/Source System Reaction Reference Comments
Whole cells: baker’s yeast BMIM-
BF6/buffer
Reduction of ketones 55 Maintenance of activity in
presence of a small aqueous phase




56 Specific activity of the biocatalyst
in the ILs-water system greater







57 Reaction rate strongly influenced
by the aw
Key: BDMIM-BF4: 1-butyl-2,3-dimethylimidazolium tetrafluoroborate
BDMIM-TFMS: 1-butyl-2,3-methylimidazolium trifluormethane sulphonate














Fig. 2. Common ionic liquids in biocatalysis: 1-butyl-3-methyl-
imidazolium tetrafluoroborate (BMIM-BF4) and hexafluoroborate
(BMIM-BF6) structures
librium position of the reaction towards synthesis. The
possibility of reusing the mixture of ionic liquid and en-
zyme was also shown.
The rule for enzyme activity in ionic liquids seems
to be »there is no rule«, since the performance in a par-
ticular ionic liquid appears to vary significantly from
enzyme to enzyme. Ionic liquids probably affect enzy-
matic activity in much the same way as the commonly
used solvents do (61).
Regarding stability in ionic liquids, it appears that
when enzymes actually dissolve in an ionic liquid they
are totally inactivated (60). To remain active in ionic liq-
uids, enzymes must remain in a powder suspension, so
that the system can be classified as a heterogeneous one.
Ionic liquids do not inactivate enzymes as hydrophilic
solvents do, which makes it possible to use ionic liquids
for the synthesis of compounds that involve polar sub-
strates, such as glucose, maltose or ascorbic acid. For in-
stance, ascorbic acid acylation in ionic liquids was en-
hanced, compared to that in organic solvents, which
Park and Kazlauskas (60) attributed to the higher solu-
bility of the substrate in the ionic liquids. The counter-
-ion can also affect stability. For lipases, methylsulfate,
nitrate and lactate counter-anions seem to render the en-
zyme inactive (61).
As is the case with reverse micelles, ionic liquids
have not yet been used in full-scale industrial processes.
Two factors may determine whether the use of ionic liq-
uids will be viable at large scale: the ability to reuse the
biocatalyst without a decrease in its activity and the abi-
lity to separate the products efficiently. Indeed, one of
the main drawbacks of the ionic liquid technique is the
difficulty of recovery of non-volatile or low volatility
products such as phenylethanol and carbohydrates. In
such cases, the recovery of the product has been attempt-
ed by pervaporation (46) and nanofiltration (59). Extrac-
tion of the product with supercritical carbon dioxide in
ionic-liquid/supercritical-CO2 mixed systems has also
been proposed (36). Finally, there is a major difficulty to
be overcome: ionic liquids are about 800 times more ex-
pensive than organic solvents (60), rendering them via-
ble only when the product is of high value.
Concluding Remarks
In this article we have shown some of the current
advances in the field of non-aqueous biocatalysis in het-
erogeneous solvent systems. Further developments in
this field are guaranteed by the ever-increasing interest
in new compounds, especially chiral compounds, since
the medium used can have significant effects on the ste-
reoselectivity of the reaction. However, many questions
still remain to be answered, especially concerning prod-
uct recovery and the cost not only of equipment but also
of non-conventional media components.
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Table 3. General structure of ionic liquids (ILs) (58,61)






































– R1: H R2: C2H5
BMPyBF4 BF4
– R1: CH3 R2: n-C4H9
EtNH3NO3 NO3
– R1: C2H5 R2, R3, R4: H
Et3MeNMeSO4 CH3OSO3
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Nevodena biokataliza u heterogenim sustavima otapala
Sa`etak
Biokataliza je postala korisna alternativa kemijskim transformacijama za proizvodnju
niza spojeva {to se primjenjuju u prehrambenoj, kemijskoj i farmaceutskoj industriji. Me-
|utim, nije tako jednostavno posti}i zadovoljavaju}u provedbu s obzirom na brzinu, isko-
ri{tenje i selektivnost reakcije. Jedna od mogu}nosti optimiranja biokataliti~kih provedaba
je kori{tenje nekonvencionalnih otapala, kao {to su nevodeni heterogeni sustavi. U radu su
prikazani neki od suvremenih tendencija u biokatalizi, provedeni u takvim sustavima s
posebnim osvrtom na reverzne micelije te superkriti~ne i ionske teku}ine.
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